Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Gvoke(Glucagon)Xeris Biopharma Holdings, Inc. logoXERS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Xeris Biopharma Holdings, Inc.

$964K

Medicare cost, 2024

Medicare drug plans spent $963,881 on Gvoke (glucagon) in 2024, for 2,163 prescriptions and refills filled by 1,557 patients. Spending rose 54% from 2023 to 2024. Ohio accounts for the most spending ($153,428, 16% of the total). It is made by Xeris Biopharma Holdings, Inc. (XERS).

Medicare cost, 2024

$964K

+54.3% from 2023

Prescriptions

2,163

$445.62 per claim

Patients

1,557

1,204 prescribers

Total spending, 2024

$964K

$619.06 per patient

Questions and answers

How much does Medicare spend on Gvoke?

Medicare prescription drug plans paid $964K for Gvoke in 2024, for 2,163 prescriptions and refills to 1,557 patients (up 54.3% from 2023). The average cost per claim was $445.62.

Which state spends the most on Gvoke?

Ohio had the highest Medicare cost for Gvoke in 2024: $153K for 158 claims, followed by New York ($80K).

Who prescribes Gvoke the most?

Angela J Houfek, physician assistant in Green Bay, WI, had the highest Medicare cost for Gvoke in 2024: 20 claims costing $12K.

Who makes Gvoke?

Gvoke is made by Xeris Biopharma Holdings, Inc. (XERS), listed in the Medicare spending data as Xeris Pharmaceu.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Gvoke was $964K in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Gvoke, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Angela J Houfek Green Bay, WIPhysician Assistant2019$12K
Keyna I Schlup Whitefish, MTFamily Practice28Under 11$10K
Reema A Patel Old Bridge, NJEndocrinology2116$9,366
Stella Ilyayeva Rego Park, NYInternal Medicine2412$9,236
Kristyn S Stevens Sylva, NCNurse Practitioner14Under 11$8,323
Paul Y Casanova-Romero Port St Lucie, FLEndocrinology2520$8,275
Marie-Noel Rahhal Twinsburg, OHEndocrinology1513$8,042
Kelby F Bethards Fort Collins, COFamily Practice13Under 11$7,016
Rafael O Robledo Hammond, LAInternal Medicine20Under 11$6,178
Jose F Bonelli Silver Spring, MDInternal Medicine1712$5,216
Elizabeth H Harris Charlotte, NCEndocrinology11Under 11$4,662
Karthik Subbu Geneva, ILInternal Medicine1514$4,639
Mary Capelety Avon, OHNurse Practitioner11Under 11$4,048
Sonum Singh Chadds Ford, PAInternal Medicine14Under 11$3,926
James G Hamilton Jr. Demorest, GAFamily Practice11Under 11$3,689
Lubaina S Presswala New York, NYEndocrinology11Under 11$3,246

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022410545471$215K
20238961,4191,079$625K
20241,2042,1631,557$964K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Xeris PharmaceuXERS logoXERS2,163$964K

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube